Journal article

High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma

Chan Yoon Cheah, David Joske, Gavin Cull, Michael Gilbertson, Stephen S Opat, Constantine S Tam, Andrew Wirth, John F Seymour

British Journal of Haematology | WILEY | Published : 2017

DOI: 10.1111/bjh.14187

Citation metrics

2Web of Science
3Scopus

Keywords

Life Sciences & Biomedicine
Rituximab
Central Nervous System Neoplasms
Hematology
Phase-Ii
Diffuse Large B-Cell Lymphoma
Involvement
Treatment Outcome
Hematopoietic Stem Cell Transplantation
Patient Selection
Autologous Stem Cell Transplant
Central Nervous System
Science & Technology
Lymphoma, Large B-Cell, Diffuse
Transplantation, Autologous
Trial
Antineoplastic Combined Chemotherapy Protocols
Non-Hodgkin-Lymphoma
Humans
Survival Analysis
Prophylaxis